Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 327 followers
Latest posts
Last updated about 6 hours ago
Ohio Bets on Workforce Training to Capture Boom in Biomanufacturing, Digital Health
about 6 hours ago
As biotech and pharma investment surges nationwide, Ohio is investing $30 million...
Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster
about 7 hours ago
After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody...
Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
about 8 hours ago
James Foster’s legendary half-century run at Charles River Laboratories is coming to...
China’s biotech moment goes global, Zai Lab exec says
about 9 hours ago
Zai Lab President and COO Josh Smiley explains how speed, scale and...
Quest, Labcorp add fully at-home STI test to women’s health offerings
about 10 hours ago
Quest and Labcorp may be archrivals in the diagnostic testing market, but...
Startup Spiro Medical snares $67M in series A funding for asthma treatment
about 11 hours ago
Spiro Medical, which debuted last year, reeled in $67 million in series...
GSK inks a model deal in $50M bet on Noetik's cancer AI platform
about 12 hours ago
GSK has committed $50 million in upfront capital and near-term milestones to...
Flagship-founded Tessera plans to lay off 90 employees in March
about 12 hours ago
Tessera Therapeutics is planning to lay off 90 employees, the Flagship-founded biotech...
Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery
about 13 hours ago
Lexeo Therapeutics is teaming up with Big Pharma’s Johnson & Johnson unit...
J&J, Google venture arms line up to back protein degradation biotech EpiBiologics' $107M series B
about 13 hours ago
Protein degradation biotech EpiBiologics has brought in $107 million in a star-studded...
Foresee offloads MMP-12 inhibitors in $584M deal, focuses on Camcevi's potential
about 14 hours ago
Foresee Pharmaceuticals has sold a chunk of its clinical-stage pipeline in order...
Equipped with $150M series A, Alveus debuts into crowded obesity development landscape
about 15 hours ago
Alveus Therapeutics, which launched Thursday under the stewardship of former I-Mab CEO...